62 related articles for article (PubMed ID: 38750462)
1. Ferredoxin 1: a gatekeeper in halting lung adenocarcinoma progression through activation of the GPRIN2 signaling pathway.
Liu M; Wu S; Wu H; Zhou Y; Zhang X; Zhu D; Jiang J
J Transl Med; 2024 May; 22(1):510. PubMed ID: 38802900
[TBL] [Abstract][Full Text] [Related]
2. FOXA1/UBE2T Inhibits CD8
Pu J; Zhang D; Wang B; Zhu P; Yang W; Wang K; Yang Z; Song Q
Front Biosci (Landmark Ed); 2024 Apr; 29(4):134. PubMed ID: 38682180
[TBL] [Abstract][Full Text] [Related]
3. UBE2T mediates SORBS3 ubiquitination to enhance IL-6/STAT3 signaling and promote lung adenocarcinoma progression.
Pu J; Wang B; Zhang D; Wang K; Yang Z; Zhu P; Song Q
J Biochem Mol Toxicol; 2024 Jun; 38(6):e23743. PubMed ID: 38816989
[TBL] [Abstract][Full Text] [Related]
4.
Feng B; Wang X; Qiu D; Sun H; Deng J; Tan Y; Ji K; Xu S; Zhang S; Tang C
Int J Mol Sci; 2024 May; 25(9):. PubMed ID: 38732173
[TBL] [Abstract][Full Text] [Related]
5. CBX4 plays a bidirectional role in transcriptional regulation and lung adenocarcinoma progression.
Zhao R; Guo Y; Zhang L; Huang Z; Li X; Lan B; Zhong D; Chen H; Xuan C
Cell Death Dis; 2024 May; 15(5):378. PubMed ID: 38816356
[TBL] [Abstract][Full Text] [Related]
6. LncARSR promotes glioma tumor growth by mediating glycolysis through the STAT3/HK2 axis.
Tian Z; Dai Q; Liu B; Lin H; Ou H
Cytokine; 2024 May; 180():156663. PubMed ID: 38815522
[TBL] [Abstract][Full Text] [Related]
7. CCT6A facilitates lung adenocarcinoma progression and glycolysis via STAT1/HK2 axis.
Yu SK; Yu T; Wang YM; Sun A; Liu J; Lu KH
J Transl Med; 2024 May; 22(1):460. PubMed ID: 38750462
[TBL] [Abstract][Full Text] [Related]
8. microRNA-184 in the landscape of human malignancies: a review to roles and clinical significance.
Fattahi M; Rezaee D; Fakhari F; Najafi S; Aghaei-Zarch SM; Beyranvand P; Rashidi MA; Bagheri-Mohammadi S; Zamani-Rarani F; Bakhtiari M; Bakhtiari A; Falahi S; Kenarkoohi A; Majidpoor J; Nguyen PU
Cell Death Discov; 2023 Nov; 9(1):423. PubMed ID: 38001121
[TBL] [Abstract][Full Text] [Related]
9. CCT8 promotes cell migration and tumor metastasis in lung adenocarcinomas.
Wu Z; Deng L; Tao J; Lu Y; Zeng X; Jia W; Chen H
J Cancer; 2023; 14(17):3238-3247. PubMed ID: 37928427
[TBL] [Abstract][Full Text] [Related]
10. Non-coding RNAs/DNMT3B axis in human cancers: from pathogenesis to clinical significance.
Huang C; Azizi P; Vazirzadeh M; Aghaei-Zarch SM; Aghaei-Zarch F; Ghanavi J; Farnia P
J Transl Med; 2023 Sep; 21(1):621. PubMed ID: 37705098
[TBL] [Abstract][Full Text] [Related]
11. The role of microRNA-185 in the pathogenesis of human diseases: A focus on cancer.
Pordel S; Khorrami M; Saadatpour F; Rezaee D; Cho WC; Jahani S; Aghaei-Zarch SM; Hashemi E; Najafi S
Pathol Res Pract; 2023 Sep; 249():154729. PubMed ID: 37639952
[TBL] [Abstract][Full Text] [Related]
12. IFI44L as a novel epigenetic silencing tumor suppressor promotes apoptosis through JAK/STAT1 pathway during lung carcinogenesis.
Zeng Y; Chen HQ; Zhang Z; Fan J; Li JZ; Zhou SM; Wang N; Yan SP; Cao J; Liu JY; Zhou ZY; Liu WB
Environ Pollut; 2023 Feb; 319():120943. PubMed ID: 36584854
[TBL] [Abstract][Full Text] [Related]
13. Cytosolic TGM2 promotes malignant progression in gastric cancer by suppressing the TRIM21-mediated ubiquitination/degradation of STAT1 in a GTP binding-dependent modality.
Zhang L; Li Q; Yang J; Xu P; Xuan Z; Xu J; Xu Z
Cancer Commun (Lond); 2023 Jan; 43(1):123-149. PubMed ID: 36353796
[TBL] [Abstract][Full Text] [Related]
14. The histone deacetylase SIRT6 promotes glycolysis through the HIF-1α/HK2 signaling axis and induces erlotinib resistance in non-small cell lung cancer.
You Q; Wang J; Yu Y; Li F; Meng L; Chen M; Yang Q; Xu Z; Sun J; Zhuo W; Chen Z
Apoptosis; 2022 Dec; 27(11-12):883-898. PubMed ID: 35915188
[TBL] [Abstract][Full Text] [Related]
15. CCT2 is an aggrephagy receptor for clearance of solid protein aggregates.
Ma X; Lu C; Chen Y; Li S; Ma N; Tao X; Li Y; Wang J; Zhou M; Yan YB; Li P; Heydari K; Deng H; Zhang M; Yi C; Ge L
Cell; 2022 Apr; 185(8):1325-1345.e22. PubMed ID: 35366418
[TBL] [Abstract][Full Text] [Related]
16. Disrupting Circadian Rhythm via the PER1-HK2 Axis Reverses Trastuzumab Resistance in Gastric Cancer.
Wang J; Huang Q; Hu X; Zhang S; Jiang Y; Yao G; Hu K; Xu X; Liang B; Wu Q; Ma Z; Wang Y; Wang C; Wu Z; Rong X; Liao W; Shi M
Cancer Res; 2022 Apr; 82(8):1503-1517. PubMed ID: 35255118
[TBL] [Abstract][Full Text] [Related]
17. Hallmarks of Cancer: New Dimensions.
Hanahan D
Cancer Discov; 2022 Jan; 12(1):31-46. PubMed ID: 35022204
[TBL] [Abstract][Full Text] [Related]
18. Targeted Therapies for Lung Cancer Patients With Oncogenic Driver Molecular Alterations.
Tan AC; Tan DSW
J Clin Oncol; 2022 Feb; 40(6):611-625. PubMed ID: 34985916
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
